ARTL
Artelo Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.91
−4.98%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.83x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 0.34x
Liquidity & coverage
- Current ratio
- 3.00x
- Quick ratio
- 3.00x
- Cash ratio
- 2.89x
- Interest coverage
- -17.91x
- EBITDA / interest
- -19.50x
- Working capital
- $2.9M
Cash & dividend
- FCF / debt
- -257.82x
- Cash flow / debt
- -257.82x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026